Literature DB >> 29729017

Risk assessment for the spread of Candida sp. in dental chair unit waterlines using molecular techniques.

Wissame Mazari1,2, Zahia Boucherit-Otmani1, Imad Abdelhamid El Haci3, Amine Ilahi2, Kebir Boucherit4.   

Abstract

AIMS: The aim of this study was to evaluate the presence of yeasts in dental chair unit waterlines (DCUWLs) and to test their ability to form biofilms.
MATERIALS AND METHODS: Eighteen dental waterlines were analysed by culture in liquid Sabouraud in order to allow the quantification and the purification of isolated yeasts from their internal surfaces. All isolates were identified by standard laboratory procedures, including CHROMagar Candida medium for orientation, commercial yeast identification system Api Candida, MALDI-TOF MS and DNA sequencing. To evaluate their kinetics of antifungal susceptibility during different phases of biofilm formation, these yeasts were subjected to three antifungal agents.
RESULTS: From the 18 DCUWLs studied, 10 were altered (55.56%). Eleven strains of Candida sp. [Candida albicans (2), Candida guilliermondii (5) and Candida glabrata (4)] and two species of non-Candida; Rhodotorula spp. (1) and Trichosporon spp. (2) were identified. The majority of yeasts in planktonic form were susceptible to amphotericin B, caspofungin and voriconazole, except C. albicans was resistant to voriconazole. In the biofilm form, caspofungin was the most effective antifungal agent for all isolated strains. For the other antifungal agents, sessile cells were resistant.
CONCLUSION: Several types of yeasts were identified; the most frequently isolated genus was Candida. The majority of these yeasts had the ability to form biofilms and resisted antifungal agents used in this study.
© 2018 FDI World Dental Federation.

Entities:  

Keywords:  Dental public health; antimicrobial resistance; biofilm; molecular genetics; mycology

Mesh:

Substances:

Year:  2018        PMID: 29729017      PMCID: PMC9379022          DOI: 10.1111/idj.12401

Source DB:  PubMed          Journal:  Int Dent J        ISSN: 0020-6539            Impact factor:   2.607


  41 in total

1.  Biofilm production and evaluation of antifungal susceptibility amongst clinical Candida spp. isolates, including strains of the Candida parapsilosis complex.

Authors:  Analy S Melo; Fernando C Bizerra; Edna Freymüller; Beth A Arthington-Skaggs; Arnaldo L Colombo
Journal:  Med Mycol       Date:  2010-11-02       Impact factor: 4.076

Review 2.  What do we know about Candida guilliermondii? A voyage throughout past and current literature about this emerging yeast.

Authors:  Vincenzo Savini; Chiara Catavitello; Daniela Onofrillo; Gioviana Masciarelli; Daniela Astolfi; Andrea Balbinot; Fabio Febbo; Claudio D'Amario; Domenico D'Antonio
Journal:  Mycoses       Date:  2010-10-29       Impact factor: 4.377

3.  In vitro growth and analysis of Candida biofilms.

Authors:  Jyotsna Chandra; Pranab K Mukherjee; Mahmoud A Ghannoum
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

4.  Voriconazole inhibits biofilm formation in different species of the genus Candida.

Authors:  A Valentín; E Cantón; J Pemán; J P Martínez
Journal:  J Antimicrob Chemother       Date:  2012-06-25       Impact factor: 5.790

Review 5.  Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumors.

Authors:  G Kovacicova; J Hanzen; M Pisarcikova; D Sejnova; J Horn; R Babela; I Svetlansky; M Lovaszova; M Gogova; V Krcmery
Journal:  J Infect Chemother       Date:  2001-03       Impact factor: 2.211

6.  Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.

Authors:  M A Pfaller; D J Diekema; M Mendez; C Kibbler; P Erzsebet; S-C Chang; D L Gibbs; V A Newell
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

7.  Biofilm formation by Candida dubliniensis.

Authors:  G Ramage; K Vande Walle; B L Wickes; J L López-Ribot
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

8.  [Catheterization and fungal infection risk in the University Hospital of Tlemcen: epidemiology and susceptibility to antifungals].

Authors:  A Seghir; Z Boucherit-Otmani; L Belkherroubi-Sari; K Boucherit
Journal:  J Mycol Med       Date:  2014-10-25       Impact factor: 2.391

9.  Liposomal amphotericin B displays rapid dose-dependent activity against Candida albicans biofilms.

Authors:  Gordon Ramage; Anto Jose; Leighann Sherry; David F Lappin; Brian Jones; Craig Williams
Journal:  Antimicrob Agents Chemother       Date:  2013-02-19       Impact factor: 5.191

10.  Clinical isolates and laboratory reference Candida species and strains have varying abilities to form biofilms.

Authors:  Ali D Alnuaimi; Neil M O'Brien-Simpson; Eric C Reynolds; Michael J McCullough
Journal:  FEMS Yeast Res       Date:  2013-09-06       Impact factor: 2.796

View more
  3 in total

1.  Molecular identification and antifungal susceptibility testing of Pucciniomycotina red yeast clinical isolates from Rio de Janeiro, Brazil.

Authors:  Fabio Brito-Santos; Maria Helena Galdino Figueiredo-Carvalho; Rowena Alves Coelho; Jean Carlos Almeida de Oliveira; Raissa Vieira Monteiro; Alessandra Leal da Silva Chaves; Rodrigo Almeida-Paes
Journal:  Braz J Microbiol       Date:  2019-11-27       Impact factor: 2.476

Review 2.  Host-microbiome interactions regarding peri-implantitis and dental implant loss.

Authors:  Carlos Henrique Alves; Karolayne Larissa Russi; Natália Conceição Rocha; Fábio Bastos; Michelle Darrieux; Thais Manzano Parisotto; Raquel Girardello
Journal:  J Transl Med       Date:  2022-09-23       Impact factor: 8.440

3.  Distinct Microbial Community of Accumulated Biofilm in Dental Unit Waterlines of Different Specialties.

Authors:  Cancan Fan; Haijing Gu; Limin Liu; Haiwei Zhu; Juan Yan; Yongbiao Huo
Journal:  Front Cell Infect Microbiol       Date:  2021-06-17       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.